| P50 | author | Kunal Sharan | Q92328753 |
| | Naibedya Chattopadhyay | Q39483750 |
| P2093 | author name string | M Mittal | |
| | B Chakravarti | |
| | R Maurya | |
| | K Khan | |
| | G K Nagar | |
| | D Yadav | |
| | P Dixit | |
| | G Swarnkar | |
| | M P Khan | |
| | S P China | |
| | T K Barbhuyan | |
| P2860 | cites work | One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women | Q24800268 |
| | Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial | Q28205266 |
| | The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis | Q28241336 |
| | Ipriflavone in the Treatment of Postmenopausal OsteoporosisA Randomized Controlled Trial | Q29040006 |
| | Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee | Q29616160 |
| | Maintenance of cortical bone in human parathyroid hormone(1-84)-treated ovariectomized rats | Q30658445 |
| | Daidzein prevents the increase in CD4+CD28null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect | Q33952238 |
| | Strontium ranelate: a novel mode of action optimizing bone formation and resorption | Q33983525 |
| | One year of alendronate treatment lowers microstructural stresses associated with trabecular microdamage initiation. | Q34053936 |
| | Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats | Q34118797 |
| | The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones | Q34162974 |
| | Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells | Q34205758 |
| | The role of phytoestrogens in the prevention and treatment of osteoporosis in ovarian hormone deficiency | Q34402903 |
| | Prevention of bone resorption by intake of phytoestrogens in postmenopausal women: a meta-analysis | Q35201099 |
| | Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies | Q35205653 |
| | Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? | Q36068139 |
| | Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone | Q71229222 |
| | Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction | Q71773689 |
| | New perspectives in the treatment of postmenopausal osteoporosis: ipriflavone | Q72523811 |
| | Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis | Q73382425 |
| | Quantification of Bone Microarchitecture with the Structure Model Index | Q73663325 |
| | Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen | Q73711545 |
| | Dose-dependent bone-sparing effects of dietary isoflavones in the ovariectomised rat | Q73741912 |
| | Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats | Q73762202 |
| | Bioavailability of nutrients and other bioactive components from dietary supplements. Proceedings of a conference. January 5-6, 2000. Bethesda, Maryland, USA | Q73855351 |
| | Effects of ipriflavone on bone loss following a bilateral ovariectomy and menopause: a randomized placebo-controlled study | Q77084114 |
| | PINP: a serum biomarker of bone formation in the rat | Q79676004 |
| | Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol | Q79859496 |
| | Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice | Q80822926 |
| | Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study | Q80836625 |
| | Estradiol rapidly inhibits osteoclastogenesis and RANKL expression in bone marrow cultures in postmenopausal women: a pilot study | Q80985294 |
| | Apoptosis induction and inhibition of hyperplasia formation by 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran in rat uterus | Q84586580 |
| | Vertebral osteoporosis and trabecular bone quality | Q36685125 |
| | The anabolic and catabolic responses in bone repair | Q36803258 |
| | Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health | Q36853704 |
| | Commentary: bioavailability of flavonoids and polyphenols: call to arms | Q36906608 |
| | Methylation of dietary flavones greatly improves their hepatic metabolic stability and intestinal absorption | Q36980660 |
| | Soy isoflavones in the management of postmenopausal osteoporosis | Q37085676 |
| | Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology. | Q37379505 |
| | Role of phytochemicals in the prevention of menopausal bone loss: evidence from in vitro and in vivo, human interventional and pharma-cokinetic studies | Q37411374 |
| | Soy isoflavones and bone mineral density in perimenopausal and postmenopausal Western women: a systematic review and meta-analysis of randomized controlled trials | Q37776734 |
| | Bone anabolic versus bone anticatabolic treatment of postmenopausal osteoporosis | Q37788771 |
| | Phytoestrogens directly inhibit TNF-α-induced bone resorption in RAW264.7 cells by suppressing c-fos-induced NFATc1 expression | Q39602490 |
| | Stimulatory effect of Daidzein in osteoblastic MC3T3-E1 cells | Q40902091 |
| | Efficacy of ipriflavone in the prevention and treatment of postmenopausal osteoporosis | Q41041173 |
| | Epidemiology of hip fractures: implications of the exponential increase with age. | Q41087496 |
| | Hip fractures in the elderly: a world-wide projection | Q41104614 |
| | Phyto-oestrogens and Western diseases | Q41501571 |
| | Total extract and standardized fraction from the stem bark of Butea monosperma have osteoprotective action: evidence for the nonestrogenic osteogenic effect of the standardized fraction | Q43097687 |
| | A novel flavonoid, 6-C-beta-d-glucopyranosyl-(2S,3S)-(+)-3',4',5,7-tetrahydroxyflavanone, isolated from Ulmus wallichiana Planchon mitigates ovariectomy-induced osteoporosis in rats | Q43099067 |
| | Effect of soy isoflavone extract supplements on bone mineral density in menopausal women: meta-analysis of randomized controlled trials | Q43143879 |
| | Extract and fraction from Ulmus wallichiana Planchon promote peak bone achievement and have a nonestrogenic osteoprotective effect | Q43222227 |
| | A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action. | Q43608666 |
| | Down-regulation of osteoclast differentiation by daidzein via caspase 3. | Q43936248 |
| | The effects of synthetic conjugated estrogens, a (cenestin) on trabecular bone structure and strength in the ovariectomized rat model | Q44178328 |
| | Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats | Q44245898 |
| | Effects of prednisone on bone mineral density and biomechanical characteristics of the femora and lumbar vertebras in rats | Q44312250 |
| | Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production | Q44356730 |
| | Osteogenic activity of constituents from Butea monosperma | Q44650985 |
| | Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats. | Q44882561 |
| | The effect of soy protein isolate on bone metabolism | Q44913646 |
| | Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats | Q45323438 |
| | Effects of Egb 761 on bone mineral density, bone microstructure, and osteoblast function: Possible roles of quercetin and kaempferol | Q46056265 |
| | Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats | Q46169161 |
| | Effects of gum arabic (Acacia senegal) on water and electrolyte balance in healthy mice | Q46759334 |
| | Short-term changes in serum PINP predict long-term changes in trabecular bone in the rat ovariectomy model | Q46791966 |
| | Estrogenic activities of isoflavones and flavones and their structure-activity relationships | Q46839845 |
| | Effect of ipriflavone--a synthetic derivative of natural isoflavones--on bone mass loss in the early years after menopause | Q47745128 |
| | A naturally occurring rare analog of quercetin promotes peak bone mass achievement and exerts anabolic effect on osteoporotic bone. | Q51517961 |
| | Quercetin-6-C-β-D-glucopyranoside isolated from Ulmus wallichiana planchon is more potent than quercetin in inhibiting osteoclastogenesis and mitigating ovariectomy-induced bone loss in rats. | Q53309371 |
| | A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss | Q57224534 |
| | Ipriflavone and low doses of estrogens in the prevention of bone mineral loss in climacterium | Q67572868 |
| | Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxidation | Q68887688 |
| | A comparison of hip fracture incidence among native Japanese, Japanese Americans, and American Caucasians | Q70143036 |
| | Frequency distributions of tetracycline-based measurements: implications for the interpretation of bone formation indices in the absence of double-labeled surfaces | Q70253218 |
| | The effect of aging and ovariectomy on the vertebral bone mass and biomechanical properties of mature rats | Q70584757 |
| | High-dose estrogen inhibits bone resorption and stimulates bone formation in the ovariectomized mouse | Q70665776 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1455-1470 | |
| P577 | publication date | 2012-08-30 | |
| P1433 | published in | Osteoporosis International | Q7107640 |
| P1476 | title | Positive skeletal effects of cladrin, a naturally occurring dimethoxydaidzein, in osteopenic rats that were maintained after treatment discontinuation | |
| P478 | volume | 24 | |